IGC Pharma, Inc.
IGC· NYSE
IGCIGC Pharma, Inc.
Quarterly figures for IGC Pharma, Inc., with source filings when available.
45 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
IGC Pharma, Inc. has filed its 10-Q within 38 to 45 days of period end across its last 8 quarters. The 10-K runs 75 to 104 days.
IGC Pharma, Inc. · CIK 1326205 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | $265.00K | −19.2% | -$0.03 | |
| Mar 31, 2026 |
| — |
| May 15, 2026 |
| 45 d |
| 10-Q |
| $317.00K |
| −3.9% |
| -$0.02 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2025 | Jun 30, 2025 | — | Aug 14, 2025 | 45 d | 10-Q | $328.00K | — | -$0.02 | |
| Q1 2025 | Mar 31, 2025 | — | — | — | — | $330.00K | — | -$0.02 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Mar 31, 2022 | — | Jun 23, 2022 | 84 d | 10-K | $122.00K | +50.6% | — | |
| Q3 2022 | Dec 31, 2021 | — | Feb 10, 2022 | 41 d | 10-Q | $142.00K | +31.5% | -$0.05 | |
| Q2 2022 | Sep 30, 2021 | — | Oct 29, 2021 | 29 d | 10-Q | $56.00K | −55.2% | -$0.09 | |
| Q1 2022 | Jun 30, 2021 | — | Aug 11, 2021 | 42 d | 10-Q | $77.00K | −86.8% | -$0.04 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Mar 31, 2021 | — | Jun 14, 2021 | 75 d | 10-K | $81.00K | +179.3% | — | |
| Q3 2021 | Dec 31, 2020 | — | Feb 16, 2021 | 47 d | 10-Q | $108.00K | −81.2% | -$0.06 | |
| Q2 2021 | Sep 30, 2020 | — | Nov 20, 2020 | 51 d | 10-Q | $125.00K | −93.1% | -$0.04 | |
| Q1 2021 | Jun 30, 2020 | — | Aug 19, 2020 | 50 d | 10-Q | $584.00K | −64.6% | -$0.05 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Mar 31, 2020 | — | Jul 13, 2020 | 104 d | 10-K | $29.00K | −98.1% | — | |
| Q3 2020 | Dec 31, 2019 | — | Feb 10, 2020 | 41 d | 10-Q | $573.00K | −55.4% | -$0.04 | |
| Q2 2020 | Sep 30, 2019 | — | Nov 6, 2019 | 37 d | 10-Q | $1.82M | +124.5% | -$0.03 | |
| Q1 2020 | Jun 30, 2019 | — | Aug 9, 2019 | 40 d | 10-Q | $1.65M | +11.6% | -$0.03 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Mar 31, 2019 | — | Jun 14, 2019 | 75 d | 10-K | $1.54M | +34.9% | — | |
| Q3 2019 | Dec 31, 2018 | — | Feb 12, 2019 | 43 d | 10-Q | $1.29M | +68.6% | -$0.03 | |
| Q2 2019 | Sep 30, 2018 | — | Oct 16, 2018 | 16 d | 10-Q | $811.00K | +245.1% | -$0.03 | |
| Q1 2019 | Jun 30, 2018 | — | Aug 3, 2018 | 34 d | 10-Q | $1.48M | +2,692.6% | -$0.02 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Mar 31, 2018 | — | Jun 21, 2018 | 82 d | 10-K | $1.14M | — | — | |
| Q3 2018 | Dec 31, 2017 | — | Feb 20, 2018 | 51 d | 10-Q | $762.00K | +205.0% | -$0.02 | |
| Q2 2018 | Sep 30, 2017 | — | Nov 17, 2017 | 48 d | 10-Q | $235.00K | +44.9% | -$0.01 | |
| Q1 2018 | Jun 30, 2017 | — | Aug 18, 2017 | 49 d | 10-Q | $52.93K | −81.7% | -$0.02 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Mar 31, 2017 | — | Jul 14, 2017 | 105 d | 10-K | — | — | — | |
| Q3 2017 | Dec 31, 2016 | — | Feb 21, 2017 | 52 d | 10-Q | $249.80K | −77.0% | $0.00 | |
| Q2 2017 | Sep 30, 2016 | — | Nov 21, 2016 | 52 d | 10-Q | $162.16K | −92.1% | -$0.02 | |
| Q1 2017 | Jun 30, 2016 | — | Aug 16, 2016 | 47 d | 10-Q | $288.49K | −84.5% | -$0.02 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Mar 31, 2016 | — | Jul 14, 2016 | 105 d | 10-K | $1.37M | −39.4% | — | |
| Q3 2016 | Dec 31, 2015 | — | Feb 16, 2016 | 47 d | 10-Q | $1.09M | −57.3% | -$0.02 | |
| Q2 2016 | Sep 30, 2015 | — | Nov 13, 2015 | 44 d | 10-Q | $2.06M | −2.9% | -$0.04 | |
| Q1 2016 | Jun 30, 2015 | — | Aug 14, 2015 | 45 d | 10-Q | $1.86M | +143.3% | -$0.03 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Mar 31, 2015 | — | Jul 14, 2015 | 105 d | 10-K | $2.26M | — | — | |
| Q3 2015 | Dec 31, 2014 | — | Feb 12, 2015 | 43 d | 10-Q | $2.54M | +14,402.8% | -$0.05 | |
| Q2 2015 | Sep 30, 2014 | — | Nov 13, 2014 | 44 d | 10-Q | $2.12M | +86.8% | -$0.07 | |
| Q1 2015 | Jun 30, 2014 | — | Aug 14, 2014 | 45 d | 10-Q | $763.86K | −32.0% | -$0.12 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Mar 31, 2014 | — | Jul 15, 2014 | 106 d | 10-K | — | — | — | |
| Q3 2014 | Dec 31, 2013 | — | Feb 14, 2014 | 45 d | 10-Q | $17.53K | — | -$0.04 | |
| Q2 2014 | Sep 30, 2013 | — | Nov 8, 2013 | 39 d | 10-Q | $1.13M | — | -$0.09 | |
| Q1 2014 | Jun 30, 2013 | — | Aug 16, 2013 | 47 d | 10-Q | $1.12M | — | -$0.09 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q1 2011 | Jun 30, 2011 | Jul 14, 2011 · after-hours | Aug 18, 2011 | 49 d | 10-Q | $1.06M | −6.0% | -$0.04 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Mar 31, 2011 | — | Jul 14, 2011 | 105 d | 10-K | $779.82K | — | — | |
| Q3 2010 | Dec 31, 2010 | — | Feb 22, 2011 | 53 d | 10-Q | $484.11K | — | -$0.12 | |
| Q2 2010 | Sep 30, 2010 | — | Nov 19, 2010 | 50 d | 10-Q | $1.68M | — | -$0.06 | |
| Q1 2010 | Jun 30, 2010 | — | Aug 16, 2010 | 47 d | 10-Q | $1.13M | — | -$0.05 | |
